The Change of Tissue Oxygen Saturation Following Volatile Anesthesia

Sponsor
Pusan National University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03060798
Collaborator
(none)
60
1
17
3.5

Study Details

Study Description

Brief Summary

General anesthesia can affect tissue oxygen saturation and microcirculatory reactivity. However, the differences in microcirculation caused by anesthetic methods have not been well studied. Near-infrared spectroscopy (NIRS) measures peripheral tissue oxygen saturation noninvasively and can be used in conjunction with vascular occlusion (VOT) experiments. The purpose of this study was to examine the changes in NIRS derived tissue oxygen saturation (StO2) and microcirculatory reactivity by VOT after inhalation anesthesia in healthy population.

This prospective, observational study will be performed on 60 healthy patients who had undergone elective surgery under volatile general anesthesia. The investigators measure StO2 and microvascular reactivity using NIRS combined with vascular occlusion test (VOT). The parameters were performed twice per patient, before and after the induction of anesthesia.

Occlusion slope and recovery slope during VOT will be compared before and after anesthesia. Moreover, the changes depend on the age will be analyzed.

Condition or Disease Intervention/Treatment Phase

Detailed Description

This prospective observational study was performed on 60 patients without comorbidities who underwent elective surgery under general anesthesia. Before and after the induction of anesthesia, StO2 monitoring and VOT were performed to investigate the effect of anesthesia on microcirculation. To investigate the effect of age on microcirculation, the patients were divided into two different groups, young (< 65 yrs) and old (> 65 yrs) groups, and the VOT-derived parameters and hemodynamics between two groups were compared.

Study Design

Study Type:
Observational
Actual Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Change of Tissue Oxygen Saturation Measured by Dynamic Near Infrared Spectroscopy Following Volatile Anesthesia in Healthy Population
Actual Study Start Date :
Aug 2, 2016
Actual Primary Completion Date :
Dec 31, 2017
Actual Study Completion Date :
Dec 31, 2017

Outcome Measures

Primary Outcome Measures

  1. Changes in Tissue Oxygen Saturation after General Anesthesia [before and 30 minutes after anesthetic induction]

    Vascular occlusion test (VOT) will be performed twice for each patient, before (T0) and 30 min after the induction of general anesthesia (T1). Before induction, a NIRS sensor will be placed on the thenar eminence and an automated tourniquet will be placed around the ipsilateral upper arm. After the baseline StO2 stabilization, the automatic tourniquet will be inflated to 50 mmHg over the patient's baseline systolic blood pressure and maintain for 5 min. After the 5-min ischemic period, the tourniquet will be rapidly deflated to 0 mmHg. StO2 data will be continuously recorded during the VOT procedure. Baseline StO2, minimum StO2 during the 5-min inflation of the tourniquet, maximum StO2 during deflation of the tourniquet, time to minimum StO2, and time to maximum StO2 will be obtained. The occlusion slope and recovery slope will be calculated based on the measured StO2 data.

Secondary Outcome Measures

  1. Age-related changes in microcirculation [before and 30 minutes after anesthetic induction]

    Patients will be divided into three groups by age (younger group: < 65 years old and older group: ≥ 65 years old) to perform age-based analysis. The acquired StO2 data by the VOT test among the groups will be analyzed and compared.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult Over 18 years of age undergoing general surgery under general anesthesia.
Exclusion Criteria:
  • ASA category III or IV, Diabetes, Chronic Kidney Disease, Vascular Disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hyeon Jeong Lee Busan Korea, Republic of 49241

Sponsors and Collaborators

  • Pusan National University Hospital

Investigators

  • Principal Investigator: Hyeon-Jeong Lee, PhD, Pusan National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hyeon-Jeong Lee, Associate Professor, Pusan National University Hospital
ClinicalTrials.gov Identifier:
NCT03060798
Other Study ID Numbers:
  • 1607-012-054
First Posted:
Feb 23, 2017
Last Update Posted:
Apr 14, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 14, 2020